Ursodiol
Back to searchMolecule Structure
Scientific Name
Ursodiol
Description of the Drug
Ursodeoxycholic acid is a bile acid used for the treatment of primary biliary cirrhosis (PBC).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01586
http://www.drugbank.ca/drugs/DB01586
Brand Name(s)
Actigall, Cholurso, Destolit, Urdox, Urso, Urso 250, Ursodiol, Ursofalk, Urso forte, Ursogal
Company Owner(s)
Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Allergan Sales Llc, Teva Pharmaceuticals Usa Inc, Abhai Llc, Vgyaan Pharmaceuticals Llc, Rising Pharmaceuticals, Teva Pharmaceuticals Usa, Lgm Pharma Solutions Llc, Epic Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bile acid receptor FXR | SINGLE PROTEIN | AGONIST | CHEMBL2047 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL27200 | |||||
| PharmGKB | PA451837 | |||||
| Human Metabolome Database | HMDB0000946 | |||||
| DrugBank | DB01586 | |||||
| PubChem: Thomson Pharma | 14756614 | 14780856 | ||||
| PubChem | 31401 | |||||
| Mcule | MCULE-4374611501 | |||||
| NMRShiftDB | 60020393 | |||||
| LINCS | LSM-6555 | |||||
| Nikkaji | J2.520H | |||||
| BindingDB | 53721 | |||||
| EPA CompTox Dashboard | DTXSID6023731 | |||||
| LipidMaps | LMST04010033 | |||||
| DrugCentral | 2797 | |||||
| Metabolights | MTBLC9907 | |||||
| Brenda | 74685 | 217849 | 23149 | 36312 | 2673 | 4288 |
| ChemicalBook | CB1285736 | |||||
| Guide to Pharmacology | 7104 | |||||
| rxnorm | URSODIOL | URSODEOXYCHOLATE | URSO | URSO FORTE | ACTIGALL | |
| PubChem: Drugs of the Future | 99431529 | |||||
| KEGG Ligand | C07880 | |||||
| ChEBI | 9907 | |||||
| ZINC | ZINC000003914809 |
